Role of amniotic membrane transplantation in ocular surface disorders
- PMID: 21505532
- DOI: 10.3126/nepjoph.v2i2.3722
Role of amniotic membrane transplantation in ocular surface disorders
Abstract
The advent of amniotic membrane (AM) and limbal stem cell grafts have transformed the treatment of diseases resulting in ocular surface failure. The current success may be attributed to cryopreservation of human AM, which retains its properties and renders the amniotic epithelial cells nonviable and thus nonimmunogenic. Its unique properties have prompted its application in a large number of ocular ailments. The present article reviews the properties of AM and its uses in ophthalmic practice.
Keywords: amniotic membrane transplantation; ocular surface disorders; chemical injury; dry eye.
© Nepal Ophthalmic Society.
Similar articles
-
Amniotic membrane transplantation with and without limbal stem cell transplantation in chemical eye injury.Nepal J Ophthalmol. 2015 Jan-Jun;7(1):52-5. doi: 10.3126/nepjoph.v7i1.13168. Nepal J Ophthalmol. 2015. PMID: 26695606
-
Serum eye drops, amniotic membrane and limbal epithelial stem cells--tools in the treatment of ocular surface disease.Cell Tissue Bank. 2010 Feb;11(1):13-27. doi: 10.1007/s10561-009-9128-1. Epub 2009 Apr 22. Cell Tissue Bank. 2010. PMID: 19387867 Review.
-
Comparative study of conjunctival limbal transplantation not associated with the use of amniotic membrane transplantation for treatment of total limbal deficiency secondary to chemical injury.Cornea. 2014 Jul;33(7):716-20. doi: 10.1097/ICO.0000000000000139. Cornea. 2014. PMID: 24831198
-
Role of amniotic membrane graft for ocular chemical and thermal injuries.Cornea. 2007 Jan;26(1):21-6. doi: 10.1097/ICO.0b013e31802b4201. Cornea. 2007. PMID: 17198009
-
Ophthalmic applications of preserved human amniotic membrane: a review of current indications.Cell Tissue Bank. 2004;5(3):161-75. doi: 10.1023/B:CATB.0000046067.25057.0a. Cell Tissue Bank. 2004. PMID: 15509905 Review.